Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes
NCT ID: NCT03272074
Last Updated: 2017-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2015-09-11
2017-08-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Egg Ingestion in Adults With Type 2 Diabetes
NCT02052037
Effect of Egg Consumption on Cardiometabolic Health in Prediabetic Subjects.
NCT03332927
Determining Dietary Pattern Accompanying Egg Intake Using Remote Food Photography Method
NCT03404700
Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects
NCT02181244
Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 Diabetes
NCT02180646
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Egg Group (Group A)
Participants will consume one large egg per day for 12 weeks
Egg and egg white
Participants will consume either one large eggs or equivalent amount of egg white (3/4 cups) for 12 weeks. Participants will maintain their regular diet and physical activities.
Egg White Group (Group B)
Participants will consume equivalent amounts of egg whites for 12 weeks
Egg and egg white
Participants will consume either one large eggs or equivalent amount of egg white (3/4 cups) for 12 weeks. Participants will maintain their regular diet and physical activities.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Egg and egg white
Participants will consume either one large eggs or equivalent amount of egg white (3/4 cups) for 12 weeks. Participants will maintain their regular diet and physical activities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With pre- and type II-diabetes. Subjects will be eligible if their Hgb A1c level is \>5.6%
Exclusion Criteria
* Uncontrolled hypertension (≥160/100 mmHg), active cancer, asthma, thyroid, glaucoma, kidney, liver and pancreatic diseases will be excluded from the study.
* Subjects who are participating in any weight loss program and/or are heavy smokers (more than 20 cigarettes per day) will be excluded from the study.
* Subjects who are allergic to egg and egg products will also be excluded from the study.
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Egg Nutrition Center
OTHER
Florida State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bahram Arjmandi
Margaret A. Sitton Professor, Director of Center for Advancing Exercise and Nutrition Research on Aging
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shirin Pourafshar, PhD
Role: STUDY_DIRECTOR
Florida State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Florida State University
Tallahassee, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015.15638
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.